Exercise-Induced Muscle Damage and Protein Intake: A Bibliometric and Visual Analysis

por Xu, Fei, Zeng, Jinshu, Liu, Xuan, Lai, Jiaming, Xu, Jing
Publicado 2022

Alterations in Circulating Bile Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis

por Lai, Jiaming, Luo, Ling, Zhou, Ting, Feng, Xiongcai, Ye, Junzhao, Zhong, Bihui
Publicado 2023

Activation of c-Jun predicts a poor response to sorafenib in hepatocellular carcinoma: Preliminary Clinical Evidence

por Chen, Wei, Xiao, Weikai, Zhang, Kunsong, Yin, Xiaoyu, Lai, Jiaming, Liang, Lijian, Chen, Dong
Publicado 2016

Overexpression of SEZ6L2 predicts poor prognosis in patients with cholangiocarcinoma

por Wang, Ziming, Lai, Jiaming, Liang, Lijian, Yin, Xiaoyu, Wang, Qian, Cheng, Quanyong, Zheng, Chaoxu
Publicado 2020

Expressional and prognostic value of HPCAL1 in cholangiocarcinoma via integrated bioinformatics analyses and experiments

por Ma, Mingjian, Zeng, Guangyan, Li, Jinhui, Liang, Jiahua, Huang, Li, Chen, Jiancong, Lai, Jiaming
Publicado 2022

MACC1 as a Prognostic Biomarker for Early-Stage and AFP-Normal Hepatocellular Carcinoma

por Xie, Chan, Wu, Jueheng, Yun, Jingping, Lai, Jiaming, Yuan, Yunfei, Gao, Zhiliang, Li, Mengfeng, Li, Jun, Song, Libing
Publicado 2013

WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer

por Huang, Shaobin, Huang, Chensong, Chen, Wei, Liu, Yifeng, Yin, Xiaoyu, Lai, Jiaming, Liang, Lijian, Wang, Qian, Wang, Anxun, Zheng, Chaoxu
Publicado 2018

Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study

por Chen, Song, Wu, Zhiqiang, Shi, Feng, Mai, Qicong, Wang, Liguang, Wang, Fan, Zhuang, Wenquan, Chen, Xiaoming, Chen, Huanwei, Xu, Bo, Lai, Jiaming, Guo, Wenbo
Publicado 2021

Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma

por Peng, Hong, Zhang, Qiuyang, Li, Jiali, Zhang, Ning, Hua, Yunpeng, Xu, Lixia, Deng, Yubin, Lai, Jiaming, Peng, Zhenwei, Peng, Baogang, Chen, Minhu, Peng, Sui, Kuang, Ming
Publicado 2016

Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vei...

por Chen, Song, Shi, Feng, Wu, Zhiqiang, Wang, Liguang, Cai, Hongjie, Ma, Ping, Zhou, Yuanmin, Mai, Qicong, Wang, Fan, Tang, Shuangyan, Zhuang, Wenquan, Lai, Jiaming, Chen, Xiaoming, Chen, Huanwei, Guo, Wenbo
Publicado 2023

Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application

por Ren, Xiaoxue, Huang, Mingle, Weng, Weixiang, Xie, Yubin, Wu, Yifan, Zhu, Shenghua, Zhang, Ying, Li, Dongming, Lai, Jiaming, Shen, Shunli, Lin, Jie, Kuang, Ming, Li, Xiaoxing, Yu, Jun, Xu, Lixia
Publicado 2023

Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China

por He, Xiaoning, Wu, Jing, Holtorf, Anke-Peggy, Rinde, Harald, Xie, Shuangshuang, Shen, Wen, Hou, Jiancun, Li, Xuehua, Li, Ziping, Lai, Jiaming, Wang, Yuting, Zhang, Lin, Wang, Jian, Li, Xuesong, Ma, Kuansheng, Ye, Feng, Ouyang, Han, Zhao, Hong
Publicado 2018